Tristel (LON:TSTL) Reaches New 52-Week Low – Should You Sell?

Tristel plc (LON:TSTL) shares reached a new 52-week low during trading on Wednesday . The company traded as low as GBX 346 ($4.52) and last traded at GBX 362 ($4.73), with a volume of 209155 shares. The stock had previously closed at GBX 357.50 ($4.67).

Tristel Trading Up 6.0 %

The business has a 50-day moving average of GBX 426.46 and a 200-day moving average of GBX 445.48. The stock has a market capitalization of £188.22 million, a price-to-earnings ratio of 3,038.46 and a beta of 0.23. The company has a debt-to-equity ratio of 19.12, a quick ratio of 3.83 and a current ratio of 4.92.

Insider Transactions at Tristel

In other news, insider Elizabeth Dixon sold 50,000 shares of the business’s stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of GBX 397 ($5.18), for a total value of £198,500 ($259,206.06). Insiders own 4.89% of the company’s stock.

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.